SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-140432
Filing Date
2019-05-08
Accepted
2019-05-08 07:01:02
Documents
3
Period of Report
2019-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d739549d8k.htm 8-K 17405
2 EX-99.1 d739549dex991.htm EX-99.1 76713
3 GRAPHIC g739549dsp04a.jpg GRAPHIC 4751
  Complete submission text file 0001193125-19-140432.txt   102136
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 19805118
SIC: 3826 Laboratory Analytical Instruments
Assistant Director 10